Status:
COMPLETED
First Presentation of Parkinson Disease Patients to Neurologist
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time
Eligibility Criteria
Inclusion
- \- Parkinson Disease patients presenting to neurologist for first time
Exclusion
- \- Hypersensitivity to the active substance or to any of the excipients
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2448 Patients enrolled
Trial Details
Trial ID
NCT00802178
Start Date
February 1 2006
Last Update
April 11 2014
Active Locations (311)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Bjelovar, Croatia
2
Boehringer Ingelheim Investigational Site
Dubrovnik, Croatia
3
Boehringer Ingelheim Investigational Site
Gospić, Croatia
4
Boehringer Ingelheim Investigational Site
Karlovac, Croatia